Summary Advocate Health Care (Advocate Health) is a nonprofit health system that provides health care services.It provides health care services such as inpatient acute and non-acute care, primary and specialty physician services and various outpatient services to communities in Illinois.
The organization provides services in the areas of cancer neurology, orthopedics and women care.Its heart Institute diagnoses and treats patients with cardiovascular conditions.
Advocate Health also has teaching affiliations with major universities in the Chicago Metropolitan area.The organization offers programs, which focus on fibrillation, congestive heart failure, cholesterol abnormalities and peripheral vascular disease.
Advocate Health is headquartered in Downers Grove, Illinois, the US.
Advocate Health Care - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
Wearable healthcare devices market to register a CAGR of 20.5% from 2020 to 2025 The global wearable healthcare devices market is projected to reach USD 46.6 billion by 2025 from USD 18.4 billion in 2020, at a CAGR of 20.5% from 2020 to 2025. The growth of the industry is driven primarily by factors such as increasing awareness...
178 pages •
By Global Industry Analysts
• May 2020
Amid the COVID-19 crisis and the looming economic recession, the Medical Device Connectivity market worldwide will grow by a projected US$3.1 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 23.6%. Solutions, one of the segments analyzed and sized in this study, is forecast to grow at over 23.1%...
544 pages •
By Global Industry Analysts
• May 2020
The global market for Optical Imaging is projected to reach US$2.5 billion by 2025, driven by the importance of medical imaging in healthcare in disease prevention, early detection, diagnosis, and treatment. Essential in the management of all virtually all medical conditions and diseases, there is growing interest in R&D of newer and more...
Keratitis - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Keratitis - Pipeline Review, H1 2020, provides an overview of the Keratitis (Ophthalmology) pipeline landscape. Keratitis is an inflammation of the cornea. Symptoms include eye redness,...
Open-angle glaucoma (OAG)–Epidemiology Forecast—2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of OAG in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. Geography Covered • The United States • EU5 (Germany, France,...
The growing prevalence of dental ailments (edentulism, dental caries, and other periodontal diseases), the increasing demand from the cosmetics dentistry, the increasing number of dental surgeries, and the increasing risks of cross-transmission are the prime factors resposnible for the growth of the dental sterilization market, currently. In...
The macular degeneration treatment market was projected to grow with a CAGR of nearly 7.4% during the forecast period. The major factors attributing to the growth of the macular degeneration treatment market are, rise in the incidence of retinal disorders, increasing the geriatric population in the majority of the developing nations. According...
The 3D printed drugsmarket was valued at US$ 28.52 million in 2019 and is expected to grow at a CAGR of 9.1% from 2020 to 2027 to reach US$ 57.03 million by 2027.The factors driving the 3D printed drugsmarketgrowth include the increasing adoption of personalized medicines, extensive research and development activities, and growing prevalence...
Pancreatitis - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Pancreatitis - Pipeline Review, H1 2020, provides an overview of the Pancreatitis (Gastrointestinal) pipeline landscape. Pancreatitis is an inflammation of pancreas. Symptoms include...